SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1627momenta conference on 17thosofun-3/11/2008
1626Momenta Pharmaceuticals Appoints Dr. James M. Roach as Chief Medical Officer Tuemopgcw-3/4/2008
1625The 55% case was supposed to be for at least 2 non-AG generics. (“At least 1” isDewDiligence_on_SI-3/3/2008
1624Actually the summary report I saw seemed pretty confused: <i>We have incrBiomaven-3/3/2008
1623FoB article in Boston Globe: siliconinvestor.comDewDiligence_on_SI-3/3/2008
1622MNTA ‘ReadMeFirst’ – <i>[Miscellaneous updates: index of anticoagulants DewDiligence_on_SI-3/2/2008
1621><i>BS has been negative for so long that a move to the long side is siDewDiligence_on_SI-2/29/2008
1620MNTA – This is identical to what Craig Wheeler told investors on the 4Q07 CC (htDewDiligence_on_SI-2/29/2008
1619Briefing.com (MNTA) Ticker Alert for In Play IRWIN JAMES FRANKEL-2/29/2008
1618BS has been negative for so long that a move to the long side is significant. TIRWIN JAMES FRANKEL-2/29/2008
1617WOW - I guess Bear had a big upgrade, but what a move, especially in this marketRocky9-2/29/2008
1616momenta has momentum.kenhott-2/29/2008
1615Updated insider shareholdings: siliconinvestor.comDewDiligence_on_SI-2/26/2008
1614On 2/22/08, MNTA issued shares and options to its six executive officers as showDewDiligence_on_SI-2/26/2008
1613Roger re the fine print. <i>>No question mnta seems a little top heavyDewDiligence_on_SI-2/26/2008
1612At the bottom, fine print, "remarks": Dr. Roach was appointed Seniorrkrw-2/26/2008
1611The SEC form says, “Senior VP, Development and Chi” — cut off just like that: seDewDiligence_on_SI-2/26/2008
1610There you go again reading too fast. Says Sr VP Development and Chief Medical rkrw-2/26/2008
1609Based on a Form-3 just filed, it looks like MNTA has a new chief business officeDewDiligence_on_SI-2/26/2008
1608It’s now official that the FDA requested immunogenicity info from Amphastar: siDewDiligence_on_SI-2/25/2008
1607Agreed.tom pope-2/18/2008
1606Thanks for the comprehensive coverage on M118. Such an effort should not pass bD.Lu-2/18/2008
1605‘ReadMeFirst’ updated again with respect to M118 program: siliconinvestor.comDewDiligence_on_SI-2/18/2008
1604‘ReadMeFirst’ updated with transcript of 4Q07 CC: siliconinvestor.comDewDiligence_on_SI-2/16/2008
1603‘ReadMeFirst’ updates: 4Q07 results; tables of holdings by major shareholders anDewDiligence_on_SI-2/15/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News